查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1179764

滅菌指示器市場：按類型、按滅菌過程、最終用戶分類：全球機會分析和行業預測，2021-2031 年

Sterility Indicators Market By Type, By Sterilization Process, By End User : Global Opportunity Analysis and Industry Forecast, 2021-2031
出版日期: | 出版商: Allied Market Research | 英文 312 Pages | 商品交期: 2-3個工作天內

價格

全球滅菌指標市場預計將在 2021 年達到 8.793 億美元，到 2031 年達到 25.993 億美元，從 2022 年到 2031 年的複合年增長率為 11.5%。我正在記錄。

滅菌指示器是一種醫療器械，用於檢測是否存在微生物。 您可以確定您的產品沒有活微生物污染。 它是用於醫療器械滅菌程序和藥物製備的重要儀器。 滅菌指示器是用來檢查滅菌質量和監控滅菌過程的指示器。 可能還需要根據滅菌質量確認是否存在微生物生長。 滅菌指示器是一種支持蒸汽滅菌過程的負荷監測、週期監測和認證的裝置。 該儀器可以證明蒸汽高壓滅菌器內的條件是否足以實現特定階段的微生物滅活。 它被視為檢查藥物製劑和醫療器械無菌質量和防止微生物滋生的重要工具。

滅菌指示器市場的驅動力來自製藥行業不斷增加的研發活動、癌症、糖尿病、關節炎和癌症等慢性病的高患病率，以及對藥品和醫療器械不斷增長的需求。 滅菌指示劑用於實驗室和製藥公司，以檢查藥品和醫療器械的無菌情況，以獲得有效的結果。 因此，慢性病的數量導致對藥品和醫療器械的需求增加。 因此，這一因素推動了製藥公司對滅菌指標的需求，並推動了市場增長。 例如，根據世界衛生組織 (WHO) 的數據，2020 年全球約有 226 萬新髮乳腺癌病例。 此外，根據國際糖尿病聯合會 (IDF) 的數據，到 2021 年，全球約有 5.37 億 20-79 歲的成年人患有糖尿病。 糖尿病患者總數預計到 2030 年將增加到 6.43 億，到 2045 年將增加到 7.83 億。

內容

第一章介紹

第 2 章執行摘要

第 3 章市場概述

  • 市場定義和範圍
  • 主要發現
    • 主要投資領域
  • 波特的五力分析
  • 主要公司的定位
  • 市場動態
    • 司機
    • 約束因素
    • 機會
  • COVID-19 影響分析

第 4 章滅菌指示器市場，按類型

  • 概覽
    • 市場規模和預測
  • 生物指標
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區
    • 市場分析：按國家/地區分類
    • 生物指示劑滅菌指示劑市場：按類型分類
      • 自給瓶市場規模轉變和預測：按地區
      • Spore Strips 市場規模和預測：按地區
      • 其他市場規模和預測：按地區
  • 化學指示劑
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區
    • 市場分析：按國家/地區分類

第 5 章滅菌指示器市場：冷處理

  • 概覽
    • 市場規模和預測
  • 蒸汽
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區
    • 市場分析：按國家/地區分類
  • 環氧乙烷
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區
    • 市場分析：按國家/地區分類
  • 乾熱
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區
    • 市場分析：按國家/地區分類
  • 其他
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區
    • 市場分析：按國家/地區分類

第 6 章滅菌指示器市場：按最終用戶分類

  • 概覽
    • 市場規模和預測
  • 醫院
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區
    • 市場分析：按國家/地區分類
  • 製藥公司、醫療器械公司
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區
    • 市場分析：按國家/地區分類
  • 臨床實驗室、研究中心
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區
    • 市場分析：按國家/地區分類

第 7 章滅菌指示器市場：按地區

  • 概覽
    • 市場規模和預測
  • 北美
    • 主要趨勢和機會
    • 北美市場規模和預測：按類型
      • 北美生物指示劑滅菌指示劑市場：按類型分類
    • 北美市場規模和預測：按滅菌工藝
    • 北美市場規模和預測：按最終用戶分類
    • 北美市場規模和預測：按國家/地區分類
      • 美國
      • 加拿大
      • 墨西哥
  • 歐洲
    • 主要趨勢和機會
    • 歐洲市場規模和預測：按類型
      • 歐洲生物指示劑滅菌指示劑市場：按類型分類
    • 歐洲市場規模和預測：按滅菌過程
    • 歐洲市場規模和預測：按最終用戶分類
    • 歐洲市場規模和預測：按國家/地區分類
      • 德國
      • 法國
      • 英國
      • 意大利
      • 西班牙
      • 其他歐洲地區
  • 亞太地區
    • 主要趨勢和機會
    • 亞太市場規模和預測：按類型
      • 亞太生物指示劑滅菌指示劑市場：按類型分類
    • 亞太市場規模和預測：按滅菌工藝
    • 亞太市場規模和預測：按最終用戶分類
    • 亞太地區的市場規模和預測：按國家/地區分類
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 其他亞太地區
  • 拉美
    • 主要趨勢和機會
    • LAMEA 市場規模和預測：按類型
      • LAMEA 生物指示劑滅菌指示劑市場：按類型分類
    • LAMEA 市場規模和預測：按滅菌工藝
    • LAMEA 市場規模和預測：按最終用戶分類
    • LAMEA 市場規模和預測：按國家/地區分類
      • 巴西
      • 沙特阿拉伯
      • 南非
      • LAMEA 的其餘部分

第八章公司情況

  • 介紹
  • 關鍵成功策略
  • 10 家主要公司的產品映射
  • 比賽儀表板
  • 競爭熱圖
  • 主要發展

第九章公司簡介

  • 3M
  • Anderson Products, Inc.
  • Fortive Corporation
  • Cardinal Health Inc.
  • Crosstex International, Inc
  • Getinge AB
  • gke GmbH
  • Hu Friedy Mfg. Co., LLC
  • Matachana Group
  • Mesa Labs, Inc.
  • MMM GROUP
  • Nelson Laboratories, LLC
  • NOXILIZER INC
  • Propper Manufacturing Co., Inc.
  • Sigma Aldrich
  • STERIS plc
  • STRYKER CORPORATION
Product Code: A29031

The global sterility indicators market was valued at $879.3 million in 2021, and is projected to reach $2,599.3 million by 2031, registering a CAGR of 11.5% from 2022 to 2031. Sterility indicators is a medical device, which is used for testing presence of microorganisms. It confirms the products are free from the presence of viable micro-organism. It is an important device used in sterilization procedure of medical device and preparation of drugs. Sterility indicators are the indicators that are used to check the quality of sterilization and monitoring of the sterilization process. It may be also required to check whether microbial growth occurs or not in terms of sterilization quality. Sterilization indicators are instruments that support load monitoring, regular monitoring, and certification of steam sterilization processes. This instrument can demonstrate whether the circumstances in steam autoclaves are enough to achieve a particular stage of microbial inactivation. It is regarded as a crucial tool for testing the sterilization quality and preventing microbiological development in pharmaceutical preparations and medical devices.

The sterility indicators market is driven by increase in R&D activities by pharmaceutical industry, high prevalence of chronic diseases such as cancer, diabetes, arthritis, and cancer, and rising demand for medicines and medical devices. Sterility indicators are used in research centers and pharmaceutical companies to check sterility of the medicine and medical device for effective results. Thus, rise in the number of chronic diseases cause increase in demand for medicines and medical device. Therefore, this factor drives the demand for sterility indicators in pharmaceutical company and drives the growth of the market. For instance, according to World Health Organization (WHO), in 2020, approximately 2.26 million new breast cancer cases were diagnosed globally. Moreover, according to International Diabetes Federation (IDF), in 2021, approximately 537 million adults in the age group of 20-79 suffered from diabetes over the globe. The total number of people suffering from diabetes is projected to rise to 643 million by 2030 and 783 million by 2045.

In addition, rise in hospital acquired infection fuels the demand for sterility indicators, which further is anticipated to boost the growth of the sterility indicators market. Growing efforts to reduce hospital acquired infections (HAIs) or nosocomial infections is one of the high impacting factors for the market growth. The concept of hospital sterile processing unit is being adopted by developing countries, such as India, China, and Middle East countries. Therefore, rise in the number of sterilization process in hospital surge the growth of the sterility indicators market. Moreover, rise in use of E-beam sterilization and increase in awareness of environmental & personal hygiene due to COVID-19 fuel the growth of the market.

In addition, rise in the number of key players who manufacture sterility indicators, increase in the product launch and product approval for sterility indicators, and rise in expenditure by government to develop healthcare infrastructure are anticipated to fuel the growth of the sterility indicators market. For instance, according to the Centers for Medicare & Medicaid Services, the U.S. healthcare spending grew by 9.7% from 2020 to 2019, reaching $4.1 trillion ($12,530 per person). Similarly, as per the Office for National Statistics, total healthcare expenditure in UK accounted for 12.8% of the gross domestic product (GDP) in 2020, as compared to 10.2% in 2019. Furthermore, it has been estimated that approximately 30% of the healthcare expenditure is used in upgrading the healthcare infrastructure, especially medical equipment and medicine used at public health centers, such as hospitals. On the other hand, sterility indicator equipment flaws like the inability to identify operational issues like overloading the sterilizer, challenging package configuration in the load, improper sterilization equipment, noncompliance with sterilization standards, high device costs, and chemical exposure hamper the growth of the sterility indicators market.

The sterility indicators market is segmented on the basis of type, sterilization process, end user, and region. By type, the market is divided into chemical indicators and biological indicators. The biological indicators is further bifurcated into self-contained vials, spore strips, and others. On the basis sterilization process, the market is segmented into steam, ethylene oxide, dry heat, and others. Others includes hydrogen peroxide and formaldehyde. On the basis of end user, the market is segmented into hospitals, pharmaceutical companies and medical device companies, and clinical laboratories/research centers. Region-wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Some of the major companies that operate in the global sterility indicators market include, 3M Company, Anderson Products, Inc., Fortive Corporation, Cardinal, Crosstex International Inc., Getinge AB, gke-GmbH, Hu-Friedy Mfg. Co., LLC, Matachana Group, Mesa Labs, Inc., MMM Group, Nelson Laboratories, LLC, NOXILIZER INC, Propper Manufacturing Co., Inc., and STERIS plc.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the sterility indicator market analysis from 2021 to 2031 to identify the prevailing sterility indicator market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the sterility indicator market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global sterility indicator market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Type

  • Biological Indicators
    • Type
    • Self contained Vials
    • Spore Strips
    • Others
  • Chemical Indicators

By Sterilization Process

  • Steam
  • Ethylene Oxide
  • Dry Heat
  • Others

By End User

  • Hospitals
  • Pharmaceutical Companies and Medical device Companies
  • Clinical laboratories and Research Centers

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA
  • Key Market Players
    • 3M
    • Anderson Products, Inc.
    • Fortive Corporation
    • Cardinal Health Inc.
    • Crosstex International, Inc
    • Getinge AB
    • gke GmbH
    • Hu Friedy Mfg. Co., LLC
    • Matachana Group
    • Mesa Labs, Inc.
    • MMM GROUP
    • Nelson Laboratories, LLC
    • NOXILIZER INC
    • Propper Manufacturing Co., Inc.
    • Sigma Aldrich
    • STERIS plc
    • STRYKER CORPORATION

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

  • 1.1.Report description
  • 1.2.Key market segments
  • 1.3.Key benefits to the stakeholders
  • 1.4.Research Methodology
    • 1.4.1.Secondary research
    • 1.4.2.Primary research
    • 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

  • 2.1.Key findings of the study
  • 2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

  • 3.1.Market definition and scope
  • 3.2.Key findings
    • 3.2.1.Top investment pockets
  • 3.3.Porter's five forces analysis
  • 3.4.Top player positioning
  • 3.5.Market dynamics
    • 3.5.1.Drivers
    • 3.5.2.Restraints
    • 3.5.3.Opportunities
  • 3.6.COVID-19 Impact Analysis on the market

CHAPTER 4: STERILITY INDICATORS MARKET, BY TYPE

  • 4.1 Overview
    • 4.1.1 Market size and forecast
  • 4.2 Biological Indicators
    • 4.2.1 Key market trends, growth factors and opportunities
    • 4.2.2 Market size and forecast, by region
    • 4.2.3 Market analysis by country
    • 4.2.4 Biological Indicators Sterility Indicators Market by Type
      • 4.2.4.1 Self contained Vials Market size and forecast, by region
      • 4.2.4.2 Spore Strips Market size and forecast, by region
      • 4.2.4.3 Others Market size and forecast, by region
  • 4.3 Chemical Indicators
    • 4.3.1 Key market trends, growth factors and opportunities
    • 4.3.2 Market size and forecast, by region
    • 4.3.3 Market analysis by country

CHAPTER 5: STERILITY INDICATORS MARKET, BY STERILIZATION PROCESS

  • 5.1 Overview
    • 5.1.1 Market size and forecast
  • 5.2 Steam
    • 5.2.1 Key market trends, growth factors and opportunities
    • 5.2.2 Market size and forecast, by region
    • 5.2.3 Market analysis by country
  • 5.3 Ethylene Oxide
    • 5.3.1 Key market trends, growth factors and opportunities
    • 5.3.2 Market size and forecast, by region
    • 5.3.3 Market analysis by country
  • 5.4 Dry Heat
    • 5.4.1 Key market trends, growth factors and opportunities
    • 5.4.2 Market size and forecast, by region
    • 5.4.3 Market analysis by country
  • 5.5 Others
    • 5.5.1 Key market trends, growth factors and opportunities
    • 5.5.2 Market size and forecast, by region
    • 5.5.3 Market analysis by country

CHAPTER 6: STERILITY INDICATORS MARKET, BY END USER

  • 6.1 Overview
    • 6.1.1 Market size and forecast
  • 6.2 Hospitals
    • 6.2.1 Key market trends, growth factors and opportunities
    • 6.2.2 Market size and forecast, by region
    • 6.2.3 Market analysis by country
  • 6.3 Pharmaceutical Companies and Medical device Companies
    • 6.3.1 Key market trends, growth factors and opportunities
    • 6.3.2 Market size and forecast, by region
    • 6.3.3 Market analysis by country
  • 6.4 Clinical laboratories and Research Centers
    • 6.4.1 Key market trends, growth factors and opportunities
    • 6.4.2 Market size and forecast, by region
    • 6.4.3 Market analysis by country

CHAPTER 7: STERILITY INDICATORS MARKET, BY REGION

  • 7.1 Overview
    • 7.1.1 Market size and forecast
  • 7.2 North America
    • 7.2.1 Key trends and opportunities
    • 7.2.2 North America Market size and forecast, by Type
      • 7.2.2.1 North America Biological Indicators Sterility Indicators Market by Type
    • 7.2.3 North America Market size and forecast, by Sterilization Process
    • 7.2.4 North America Market size and forecast, by End User
    • 7.2.5 North America Market size and forecast, by country
      • 7.2.5.1 U.S.
      • 7.2.5.1.1 Market size and forecast, by Type
      • 7.2.5.1.2 Market size and forecast, by Sterilization Process
      • 7.2.5.1.3 Market size and forecast, by End User
      • 7.2.5.2 Canada
      • 7.2.5.2.1 Market size and forecast, by Type
      • 7.2.5.2.2 Market size and forecast, by Sterilization Process
      • 7.2.5.2.3 Market size and forecast, by End User
      • 7.2.5.3 Mexico
      • 7.2.5.3.1 Market size and forecast, by Type
      • 7.2.5.3.2 Market size and forecast, by Sterilization Process
      • 7.2.5.3.3 Market size and forecast, by End User
  • 7.3 Europe
    • 7.3.1 Key trends and opportunities
    • 7.3.2 Europe Market size and forecast, by Type
      • 7.3.2.1 Europe Biological Indicators Sterility Indicators Market by Type
    • 7.3.3 Europe Market size and forecast, by Sterilization Process
    • 7.3.4 Europe Market size and forecast, by End User
    • 7.3.5 Europe Market size and forecast, by country
      • 7.3.5.1 Germany
      • 7.3.5.1.1 Market size and forecast, by Type
      • 7.3.5.1.2 Market size and forecast, by Sterilization Process
      • 7.3.5.1.3 Market size and forecast, by End User
      • 7.3.5.2 France
      • 7.3.5.2.1 Market size and forecast, by Type
      • 7.3.5.2.2 Market size and forecast, by Sterilization Process
      • 7.3.5.2.3 Market size and forecast, by End User
      • 7.3.5.3 UK
      • 7.3.5.3.1 Market size and forecast, by Type
      • 7.3.5.3.2 Market size and forecast, by Sterilization Process
      • 7.3.5.3.3 Market size and forecast, by End User
      • 7.3.5.4 Italy
      • 7.3.5.4.1 Market size and forecast, by Type
      • 7.3.5.4.2 Market size and forecast, by Sterilization Process
      • 7.3.5.4.3 Market size and forecast, by End User
      • 7.3.5.5 Spain
      • 7.3.5.5.1 Market size and forecast, by Type
      • 7.3.5.5.2 Market size and forecast, by Sterilization Process
      • 7.3.5.5.3 Market size and forecast, by End User
      • 7.3.5.6 Rest of Europe
      • 7.3.5.6.1 Market size and forecast, by Type
      • 7.3.5.6.2 Market size and forecast, by Sterilization Process
      • 7.3.5.6.3 Market size and forecast, by End User
  • 7.4 Asia-Pacific
    • 7.4.1 Key trends and opportunities
    • 7.4.2 Asia-Pacific Market size and forecast, by Type
      • 7.4.2.1 Asia-Pacific Biological Indicators Sterility Indicators Market by Type
    • 7.4.3 Asia-Pacific Market size and forecast, by Sterilization Process
    • 7.4.4 Asia-Pacific Market size and forecast, by End User
    • 7.4.5 Asia-Pacific Market size and forecast, by country
      • 7.4.5.1 China
      • 7.4.5.1.1 Market size and forecast, by Type
      • 7.4.5.1.2 Market size and forecast, by Sterilization Process
      • 7.4.5.1.3 Market size and forecast, by End User
      • 7.4.5.2 Japan
      • 7.4.5.2.1 Market size and forecast, by Type
      • 7.4.5.2.2 Market size and forecast, by Sterilization Process
      • 7.4.5.2.3 Market size and forecast, by End User
      • 7.4.5.3 India
      • 7.4.5.3.1 Market size and forecast, by Type
      • 7.4.5.3.2 Market size and forecast, by Sterilization Process
      • 7.4.5.3.3 Market size and forecast, by End User
      • 7.4.5.4 Australia
      • 7.4.5.4.1 Market size and forecast, by Type
      • 7.4.5.4.2 Market size and forecast, by Sterilization Process
      • 7.4.5.4.3 Market size and forecast, by End User
      • 7.4.5.5 South Korea
      • 7.4.5.5.1 Market size and forecast, by Type
      • 7.4.5.5.2 Market size and forecast, by Sterilization Process
      • 7.4.5.5.3 Market size and forecast, by End User
      • 7.4.5.6 Rest of Asia-Pacific
      • 7.4.5.6.1 Market size and forecast, by Type
      • 7.4.5.6.2 Market size and forecast, by Sterilization Process
      • 7.4.5.6.3 Market size and forecast, by End User
  • 7.5 LAMEA
    • 7.5.1 Key trends and opportunities
    • 7.5.2 LAMEA Market size and forecast, by Type
      • 7.5.2.1 LAMEA Biological Indicators Sterility Indicators Market by Type
    • 7.5.3 LAMEA Market size and forecast, by Sterilization Process
    • 7.5.4 LAMEA Market size and forecast, by End User
    • 7.5.5 LAMEA Market size and forecast, by country
      • 7.5.5.1 Brazil
      • 7.5.5.1.1 Market size and forecast, by Type
      • 7.5.5.1.2 Market size and forecast, by Sterilization Process
      • 7.5.5.1.3 Market size and forecast, by End User
      • 7.5.5.2 Saudi Arabia
      • 7.5.5.2.1 Market size and forecast, by Type
      • 7.5.5.2.2 Market size and forecast, by Sterilization Process
      • 7.5.5.2.3 Market size and forecast, by End User
      • 7.5.5.3 South Africa
      • 7.5.5.3.1 Market size and forecast, by Type
      • 7.5.5.3.2 Market size and forecast, by Sterilization Process
      • 7.5.5.3.3 Market size and forecast, by End User
      • 7.5.5.4 Rest of LAMEA
      • 7.5.5.4.1 Market size and forecast, by Type
      • 7.5.5.4.2 Market size and forecast, by Sterilization Process
      • 7.5.5.4.3 Market size and forecast, by End User

CHAPTER 8: COMPANY LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top winning strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Key developments

CHAPTER 9: COMPANY PROFILES

  • 9.1 3M
    • 9.1.1 Company overview
    • 9.1.2 Company snapshot
    • 9.1.3 Operating business segments
    • 9.1.4 Product portfolio
    • 9.1.5 Business performance
    • 9.1.6 Key strategic moves and developments
  • 9.2 Anderson Products, Inc.
    • 9.2.1 Company overview
    • 9.2.2 Company snapshot
    • 9.2.3 Operating business segments
    • 9.2.4 Product portfolio
    • 9.2.5 Business performance
    • 9.2.6 Key strategic moves and developments
  • 9.3 Fortive Corporation
    • 9.3.1 Company overview
    • 9.3.2 Company snapshot
    • 9.3.3 Operating business segments
    • 9.3.4 Product portfolio
    • 9.3.5 Business performance
    • 9.3.6 Key strategic moves and developments
  • 9.4 Cardinal Health Inc.
    • 9.4.1 Company overview
    • 9.4.2 Company snapshot
    • 9.4.3 Operating business segments
    • 9.4.4 Product portfolio
    • 9.4.5 Business performance
    • 9.4.6 Key strategic moves and developments
  • 9.5 Crosstex International, Inc
    • 9.5.1 Company overview
    • 9.5.2 Company snapshot
    • 9.5.3 Operating business segments
    • 9.5.4 Product portfolio
    • 9.5.5 Business performance
    • 9.5.6 Key strategic moves and developments
  • 9.6 Getinge AB
    • 9.6.1 Company overview
    • 9.6.2 Company snapshot
    • 9.6.3 Operating business segments
    • 9.6.4 Product portfolio
    • 9.6.5 Business performance
    • 9.6.6 Key strategic moves and developments
  • 9.7 gke GmbH
    • 9.7.1 Company overview
    • 9.7.2 Company snapshot
    • 9.7.3 Operating business segments
    • 9.7.4 Product portfolio
    • 9.7.5 Business performance
    • 9.7.6 Key strategic moves and developments
  • 9.8 Hu Friedy Mfg. Co., LLC
    • 9.8.1 Company overview
    • 9.8.2 Company snapshot
    • 9.8.3 Operating business segments
    • 9.8.4 Product portfolio
    • 9.8.5 Business performance
    • 9.8.6 Key strategic moves and developments
  • 9.9 Matachana Group
    • 9.9.1 Company overview
    • 9.9.2 Company snapshot
    • 9.9.3 Operating business segments
    • 9.9.4 Product portfolio
    • 9.9.5 Business performance
    • 9.9.6 Key strategic moves and developments
  • 9.10 Mesa Labs, Inc.
    • 9.10.1 Company overview
    • 9.10.2 Company snapshot
    • 9.10.3 Operating business segments
    • 9.10.4 Product portfolio
    • 9.10.5 Business performance
    • 9.10.6 Key strategic moves and developments
  • 9.11 MMM GROUP
    • 9.11.1 Company overview
    • 9.11.2 Company snapshot
    • 9.11.3 Operating business segments
    • 9.11.4 Product portfolio
    • 9.11.5 Business performance
    • 9.11.6 Key strategic moves and developments
  • 9.12 Nelson Laboratories, LLC
    • 9.12.1 Company overview
    • 9.12.2 Company snapshot
    • 9.12.3 Operating business segments
    • 9.12.4 Product portfolio
    • 9.12.5 Business performance
    • 9.12.6 Key strategic moves and developments
  • 9.13 NOXILIZER INC
    • 9.13.1 Company overview
    • 9.13.2 Company snapshot
    • 9.13.3 Operating business segments
    • 9.13.4 Product portfolio
    • 9.13.5 Business performance
    • 9.13.6 Key strategic moves and developments
  • 9.14 Propper Manufacturing Co., Inc.
    • 9.14.1 Company overview
    • 9.14.2 Company snapshot
    • 9.14.3 Operating business segments
    • 9.14.4 Product portfolio
    • 9.14.5 Business performance
    • 9.14.6 Key strategic moves and developments
  • 9.15 Sigma Aldrich
    • 9.15.1 Company overview
    • 9.15.2 Company snapshot
    • 9.15.3 Operating business segments
    • 9.15.4 Product portfolio
    • 9.15.5 Business performance
    • 9.15.6 Key strategic moves and developments
  • 9.16 STERIS plc
    • 9.16.1 Company overview
    • 9.16.2 Company snapshot
    • 9.16.3 Operating business segments
    • 9.16.4 Product portfolio
    • 9.16.5 Business performance
    • 9.16.6 Key strategic moves and developments
  • 9.17 STRYKER CORPORATION
    • 9.17.1 Company overview
    • 9.17.2 Company snapshot
    • 9.17.3 Operating business segments
    • 9.17.4 Product portfolio
    • 9.17.5 Business performance
    • 9.17.6 Key strategic moves and developments

LIST OF TABLES

  • TABLE 1. GLOBAL STERILITY INDICATORS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 2. STERILITY INDICATORS MARKET, FOR BIOLOGICAL INDICATORS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 3. STERILITY INDICATORS MARKET FOR BIOLOGICAL INDICATORS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 4. GLOBAL BIOLOGICAL INDICATORS STERILITY INDICATORS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 5. STERILITY INDICATORS MARKET, FOR SELF CONTAINED VIALS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 6. STERILITY INDICATORS MARKET, FOR SPORE STRIPS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 7. STERILITY INDICATORS MARKET, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 8. STERILITY INDICATORS MARKET, FOR CHEMICAL INDICATORS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 9. STERILITY INDICATORS MARKET FOR CHEMICAL INDICATORS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 10. GLOBAL STERILITY INDICATORS MARKET, BY STERILIZATION PROCESS, 2021-2031 ($MILLION)
  • TABLE 11. STERILITY INDICATORS MARKET, FOR STEAM, BY REGION, 2021-2031 ($MILLION)
  • TABLE 12. STERILITY INDICATORS MARKET FOR STEAM, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 13. STERILITY INDICATORS MARKET, FOR ETHYLENE OXIDE, BY REGION, 2021-2031 ($MILLION)
  • TABLE 14. STERILITY INDICATORS MARKET FOR ETHYLENE OXIDE, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 15. STERILITY INDICATORS MARKET, FOR DRY HEAT, BY REGION, 2021-2031 ($MILLION)
  • TABLE 16. STERILITY INDICATORS MARKET FOR DRY HEAT, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 17. STERILITY INDICATORS MARKET, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 18. STERILITY INDICATORS MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 19. GLOBAL STERILITY INDICATORS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 20. STERILITY INDICATORS MARKET, FOR HOSPITALS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 21. STERILITY INDICATORS MARKET FOR HOSPITALS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 22. STERILITY INDICATORS MARKET, FOR PHARMACEUTICAL COMPANIES AND MEDICAL DEVICE COMPANIES, BY REGION, 2021-2031 ($MILLION)
  • TABLE 23. STERILITY INDICATORS MARKET FOR PHARMACEUTICAL COMPANIES AND MEDICAL DEVICE COMPANIES, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 24. STERILITY INDICATORS MARKET, FOR CLINICAL LABORATORIES AND RESEARCH CENTERS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 25. STERILITY INDICATORS MARKET FOR CLINICAL LABORATORIES AND RESEARCH CENTERS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 26. STERILITY INDICATORS MARKET, BY REGION, 2021-2031 ($MILLION)
  • TABLE 27. NORTH AMERICA STERILITY INDICATORS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 28. NORTH AMERICA BIOLOGICAL INDICATORS STERILITY INDICATORS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 29. NORTH AMERICA STERILITY INDICATORS MARKET, BY STERILIZATION PROCESS, 2021-2031 ($MILLION)
  • TABLE 30. NORTH AMERICA STERILITY INDICATORS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 31. NORTH AMERICA STERILITY INDICATORS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 32. U.S. STERILITY INDICATORS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 33. U.S. STERILITY INDICATORS MARKET, BY STERILIZATION PROCESS, 2021-2031 ($MILLION)
  • TABLE 34. U.S. STERILITY INDICATORS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 35. CANADA STERILITY INDICATORS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 36. CANADA STERILITY INDICATORS MARKET, BY STERILIZATION PROCESS, 2021-2031 ($MILLION)
  • TABLE 37. CANADA STERILITY INDICATORS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 38. MEXICO STERILITY INDICATORS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 39. MEXICO STERILITY INDICATORS MARKET, BY STERILIZATION PROCESS, 2021-2031 ($MILLION)
  • TABLE 40. MEXICO STERILITY INDICATORS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 41. EUROPE STERILITY INDICATORS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 42. EUROPE BIOLOGICAL INDICATORS STERILITY INDICATORS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 43. EUROPE STERILITY INDICATORS MARKET, BY STERILIZATION PROCESS, 2021-2031 ($MILLION)
  • TABLE 44. EUROPE STERILITY INDICATORS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 45. EUROPE STERILITY INDICATORS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 46. GERMANY STERILITY INDICATORS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 47. GERMANY STERILITY INDICATORS MARKET, BY STERILIZATION PROCESS, 2021-2031 ($MILLION)
  • TABLE 48. GERMANY STERILITY INDICATORS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 49. FRANCE STERILITY INDICATORS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 50. FRANCE STERILITY INDICATORS MARKET, BY STERILIZATION PROCESS, 2021-2031 ($MILLION)
  • TABLE 51. FRANCE STERILITY INDICATORS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 52. UK STERILITY INDICATORS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 53. UK STERILITY INDICATORS MARKET, BY STERILIZATION PROCESS, 2021-2031 ($MILLION)
  • TABLE 54. UK STERILITY INDICATORS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 55. ITALY STERILITY INDICATORS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 56. ITALY STERILITY INDICATORS MARKET, BY STERILIZATION PROCESS, 2021-2031 ($MILLION)
  • TABLE 57. ITALY STERILITY INDICATORS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 58. SPAIN STERILITY INDICATORS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 59. SPAIN STERILITY INDICATORS MARKET, BY STERILIZATION PROCESS, 2021-2031 ($MILLION)
  • TABLE 60. SPAIN STERILITY INDICATORS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 61. REST OF EUROPE STERILITY INDICATORS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 62. REST OF EUROPE STERILITY INDICATORS MARKET, BY STERILIZATION PROCESS, 2021-2031 ($MILLION)
  • TABLE 63. REST OF EUROPE STERILITY INDICATORS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 64. ASIA-PACIFIC STERILITY INDICATORS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 65. ASIA-PACIFIC BIOLOGICAL INDICATORS STERILITY INDICATORS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 66. ASIA-PACIFIC STERILITY INDICATORS MARKET, BY STERILIZATION PROCESS, 2021-2031 ($MILLION)
  • TABLE 67. ASIA-PACIFIC STERILITY INDICATORS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 68. ASIA-PACIFIC STERILITY INDICATORS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 69. CHINA STERILITY INDICATORS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 70. CHINA STERILITY INDICATORS MARKET, BY STERILIZATION PROCESS, 2021-2031 ($MILLION)
  • TABLE 71. CHINA STERILITY INDICATORS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 72. JAPAN STERILITY INDICATORS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 73. JAPAN STERILITY INDICATORS MARKET, BY STERILIZATION PROCESS, 2021-2031 ($MILLION)
  • TABLE 74. JAPAN STERILITY INDICATORS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 75. INDIA STERILITY INDICATORS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 76. INDIA STERILITY INDICATORS MARKET, BY STERILIZATION PROCESS, 2021-2031 ($MILLION)
  • TABLE 77. INDIA STERILITY INDICATORS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 78. AUSTRALIA STERILITY INDICATORS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 79. AUSTRALIA STERILITY INDICATORS MARKET, BY STERILIZATION PROCESS, 2021-2031 ($MILLION)
  • TABLE 80. AUSTRALIA STERILITY INDICATORS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 81. SOUTH KOREA STERILITY INDICATORS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 82. SOUTH KOREA STERILITY INDICATORS MARKET, BY STERILIZATION PROCESS, 2021-2031 ($MILLION)
  • TABLE 83. SOUTH KOREA STERILITY INDICATORS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 84. REST OF ASIA-PACIFIC STERILITY INDICATORS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 85. REST OF ASIA-PACIFIC STERILITY INDICATORS MARKET, BY STERILIZATION PROCESS, 2021-2031 ($MILLION)
  • TABLE 86. REST OF ASIA-PACIFIC STERILITY INDICATORS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 87. LAMEA STERILITY INDICATORS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 88. LAMEA BIOLOGICAL INDICATORS STERILITY INDICATORS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 89. LAMEA STERILITY INDICATORS MARKET, BY STERILIZATION PROCESS, 2021-2031 ($MILLION)
  • TABLE 90. LAMEA STERILITY INDICATORS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 91. LAMEA STERILITY INDICATORS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 92. BRAZIL STERILITY INDICATORS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 93. BRAZIL STERILITY INDICATORS MARKET, BY STERILIZATION PROCESS, 2021-2031 ($MILLION)
  • TABLE 94. BRAZIL STERILITY INDICATORS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 95. SAUDI ARABIA STERILITY INDICATORS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 96. SAUDI ARABIA STERILITY INDICATORS MARKET, BY STERILIZATION PROCESS, 2021-2031 ($MILLION)
  • TABLE 97. SAUDI ARABIA STERILITY INDICATORS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 98. SOUTH AFRICA STERILITY INDICATORS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 99. SOUTH AFRICA STERILITY INDICATORS MARKET, BY STERILIZATION PROCESS, 2021-2031 ($MILLION)
  • TABLE 100. SOUTH AFRICA STERILITY INDICATORS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 101. REST OF LAMEA STERILITY INDICATORS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 102. REST OF LAMEA STERILITY INDICATORS MARKET, BY STERILIZATION PROCESS, 2021-2031 ($MILLION)
  • TABLE 103. REST OF LAMEA STERILITY INDICATORS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 104.3M: COMPANY SNAPSHOT
  • TABLE 105.3M: OPERATING SEGMENTS
  • TABLE 106.3M: PRODUCT PORTFOLIO
  • TABLE 107.3M: NET SALES,
  • TABLE 108.3M: KEY STRATERGIES
  • TABLE 109.ANDERSON PRODUCTS, INC.: COMPANY SNAPSHOT
  • TABLE 110.ANDERSON PRODUCTS, INC.: OPERATING SEGMENTS
  • TABLE 111.ANDERSON PRODUCTS, INC.: PRODUCT PORTFOLIO
  • TABLE 112.ANDERSON PRODUCTS, INC.: NET SALES,
  • TABLE 113.ANDERSON PRODUCTS, INC.: KEY STRATERGIES
  • TABLE 114.FORTIVE CORPORATION: COMPANY SNAPSHOT
  • TABLE 115.FORTIVE CORPORATION: OPERATING SEGMENTS
  • TABLE 116.FORTIVE CORPORATION: PRODUCT PORTFOLIO
  • TABLE 117.FORTIVE CORPORATION: NET SALES,
  • TABLE 118.FORTIVE CORPORATION: KEY STRATERGIES
  • TABLE 119.CARDINAL HEALTH INC.: COMPANY SNAPSHOT
  • TABLE 120.CARDINAL HEALTH INC.: OPERATING SEGMENTS
  • TABLE 121.CARDINAL HEALTH INC.: PRODUCT PORTFOLIO
  • TABLE 122.CARDINAL HEALTH INC.: NET SALES,
  • TABLE 123.CARDINAL HEALTH INC.: KEY STRATERGIES
  • TABLE 124.CROSSTEX INTERNATIONAL, INC: COMPANY SNAPSHOT
  • TABLE 125.CROSSTEX INTERNATIONAL, INC: OPERATING SEGMENTS
  • TABLE 126.CROSSTEX INTERNATIONAL, INC: PRODUCT PORTFOLIO
  • TABLE 127.CROSSTEX INTERNATIONAL, INC: NET SALES,
  • TABLE 128.CROSSTEX INTERNATIONAL, INC: KEY STRATERGIES
  • TABLE 129.GETINGE AB: COMPANY SNAPSHOT
  • TABLE 130.GETINGE AB: OPERATING SEGMENTS
  • TABLE 131.GETINGE AB: PRODUCT PORTFOLIO
  • TABLE 132.GETINGE AB: NET SALES,
  • TABLE 133.GETINGE AB: KEY STRATERGIES
  • TABLE 134.GKE GMBH: COMPANY SNAPSHOT
  • TABLE 135.GKE GMBH: OPERATING SEGMENTS
  • TABLE 136.GKE GMBH: PRODUCT PORTFOLIO
  • TABLE 137.GKE GMBH: NET SALES,
  • TABLE 138.GKE GMBH: KEY STRATERGIES
  • TABLE 139.HU FRIEDY MFG. CO., LLC: COMPANY SNAPSHOT
  • TABLE 140.HU FRIEDY MFG. CO., LLC: OPERATING SEGMENTS
  • TABLE 141.HU FRIEDY MFG. CO., LLC: PRODUCT PORTFOLIO
  • TABLE 142.HU FRIEDY MFG. CO., LLC: NET SALES,
  • TABLE 143.HU FRIEDY MFG. CO., LLC: KEY STRATERGIES
  • TABLE 144.MATACHANA GROUP: COMPANY SNAPSHOT
  • TABLE 145.MATACHANA GROUP: OPERATING SEGMENTS
  • TABLE 146.MATACHANA GROUP: PRODUCT PORTFOLIO
  • TABLE 147.MATACHANA GROUP: NET SALES,
  • TABLE 148.MATACHANA GROUP: KEY STRATERGIES
  • TABLE 149.MESA LABS, INC.: COMPANY SNAPSHOT
  • TABLE 150.MESA LABS, INC.: OPERATING SEGMENTS
  • TABLE 151.MESA LABS, INC.: PRODUCT PORTFOLIO
  • TABLE 152.MESA LABS, INC.: NET SALES,
  • TABLE 153.MESA LABS, INC.: KEY STRATERGIES
  • TABLE 154.MMM GROUP: COMPANY SNAPSHOT
  • TABLE 155.MMM GROUP: OPERATING SEGMENTS
  • TABLE 156.MMM GROUP: PRODUCT PORTFOLIO
  • TABLE 157.MMM GROUP: NET SALES,
  • TABLE 158.MMM GROUP: KEY STRATERGIES
  • TABLE 159.NELSON LABORATORIES, LLC: COMPANY SNAPSHOT
  • TABLE 160.NELSON LABORATORIES, LLC: OPERATING SEGMENTS
  • TABLE 161.NELSON LABORATORIES, LLC: PRODUCT PORTFOLIO
  • TABLE 162.NELSON LABORATORIES, LLC: NET SALES,
  • TABLE 163.NELSON LABORATORIES, LLC: KEY STRATERGIES
  • TABLE 164.NOXILIZER INC: COMPANY SNAPSHOT
  • TABLE 165.NOXILIZER INC: OPERATING SEGMENTS
  • TABLE 166.NOXILIZER INC: PRODUCT PORTFOLIO
  • TABLE 167.NOXILIZER INC: NET SALES,
  • TABLE 168.NOXILIZER INC: KEY STRATERGIES
  • TABLE 169.PROPPER MANUFACTURING CO., INC.: COMPANY SNAPSHOT
  • TABLE 170.PROPPER MANUFACTURING CO., INC.: OPERATING SEGMENTS
  • TABLE 171.PROPPER MANUFACTURING CO., INC.: PRODUCT PORTFOLIO
  • TABLE 172.PROPPER MANUFACTURING CO., INC.: NET SALES,
  • TABLE 173.PROPPER MANUFACTURING CO., INC.: KEY STRATERGIES
  • TABLE 174.SIGMA ALDRICH: COMPANY SNAPSHOT
  • TABLE 175.SIGMA ALDRICH: OPERATING SEGMENTS
  • TABLE 176.SIGMA ALDRICH: PRODUCT PORTFOLIO
  • TABLE 177.SIGMA ALDRICH: NET SALES,
  • TABLE 178.SIGMA ALDRICH: KEY STRATERGIES
  • TABLE 179.STERIS PLC: COMPANY SNAPSHOT
  • TABLE 180.STERIS PLC: OPERATING SEGMENTS
  • TABLE 181.STERIS PLC: PRODUCT PORTFOLIO
  • TABLE 182.STERIS PLC: NET SALES,
  • TABLE 183.STERIS PLC: KEY STRATERGIES
  • TABLE 184.STRYKER CORPORATION: COMPANY SNAPSHOT
  • TABLE 185.STRYKER CORPORATION: OPERATING SEGMENTS
  • TABLE 186.STRYKER CORPORATION: PRODUCT PORTFOLIO
  • TABLE 187.STRYKER CORPORATION: NET SALES,
  • TABLE 188.STRYKER CORPORATION: KEY STRATERGIES

LIST OF FIGURES

  • FIGURE 1.STERILITY INDICATORS MARKET SEGMENTATION
  • FIGURE 2.STERILITY INDICATORS MARKET,2021-2031
  • FIGURE 3.STERILITY INDICATORS MARKET,2021-2031
  • FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
  • FIGURE 5.PORTER FIVE-1
  • FIGURE 6.PORTER FIVE-2
  • FIGURE 7.PORTER FIVE-3
  • FIGURE 8.PORTER FIVE-4
  • FIGURE 9.PORTER FIVE-5
  • FIGURE 10.TOP PLAYER POSITIONING
  • FIGURE 11.STERILITY INDICATORS MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
  • FIGURE 12.STERILITY INDICATORS MARKET,BY TYPE,2021(%)
  • FIGURE 13.COMPARATIVE SHARE ANALYSIS OF BIOLOGICAL INDICATORS STERILITY INDICATORS MARKET,2021-2031(%)
  • FIGURE 14.COMPARATIVE SHARE ANALYSIS OF CHEMICAL INDICATORS STERILITY INDICATORS MARKET,2021-2031(%)
  • FIGURE 15.STERILITY INDICATORS MARKET,BY STERILIZATION PROCESS,2021(%)
  • FIGURE 16.COMPARATIVE SHARE ANALYSIS OF STEAM STERILITY INDICATORS MARKET,2021-2031(%)
  • FIGURE 17.COMPARATIVE SHARE ANALYSIS OF ETHYLENE OXIDE STERILITY INDICATORS MARKET,2021-2031(%)
  • FIGURE 18.COMPARATIVE SHARE ANALYSIS OF DRY HEAT STERILITY INDICATORS MARKET,2021-2031(%)
  • FIGURE 19.COMPARATIVE SHARE ANALYSIS OF OTHERS STERILITY INDICATORS MARKET,2021-2031(%)
  • FIGURE 20.STERILITY INDICATORS MARKET,BY END USER,2021(%)
  • FIGURE 21.COMPARATIVE SHARE ANALYSIS OF HOSPITALS STERILITY INDICATORS MARKET,2021-2031(%)
  • FIGURE 22.COMPARATIVE SHARE ANALYSIS OF PHARMACEUTICAL COMPANIES AND MEDICAL DEVICE COMPANIES STERILITY INDICATORS MARKET,2021-2031(%)
  • FIGURE 23.COMPARATIVE SHARE ANALYSIS OF CLINICAL LABORATORIES AND RESEARCH CENTERS STERILITY INDICATORS MARKET,2021-2031(%)
  • FIGURE 24.STERILITY INDICATORS MARKET BY REGION,2021
  • FIGURE 25.U.S. STERILITY INDICATORS MARKET,2021-2031($MILLION)
  • FIGURE 26.CANADA STERILITY INDICATORS MARKET,2021-2031($MILLION)
  • FIGURE 27.MEXICO STERILITY INDICATORS MARKET,2021-2031($MILLION)
  • FIGURE 28.GERMANY STERILITY INDICATORS MARKET,2021-2031($MILLION)
  • FIGURE 29.FRANCE STERILITY INDICATORS MARKET,2021-2031($MILLION)
  • FIGURE 30.UK STERILITY INDICATORS MARKET,2021-2031($MILLION)
  • FIGURE 31.ITALY STERILITY INDICATORS MARKET,2021-2031($MILLION)
  • FIGURE 32.SPAIN STERILITY INDICATORS MARKET,2021-2031($MILLION)
  • FIGURE 33.REST OF EUROPE STERILITY INDICATORS MARKET,2021-2031($MILLION)
  • FIGURE 34.CHINA STERILITY INDICATORS MARKET,2021-2031($MILLION)
  • FIGURE 35.JAPAN STERILITY INDICATORS MARKET,2021-2031($MILLION)
  • FIGURE 36.INDIA STERILITY INDICATORS MARKET,2021-2031($MILLION)
  • FIGURE 37.AUSTRALIA STERILITY INDICATORS MARKET,2021-2031($MILLION)
  • FIGURE 38.SOUTH KOREA STERILITY INDICATORS MARKET,2021-2031($MILLION)
  • FIGURE 39.REST OF ASIA-PACIFIC STERILITY INDICATORS MARKET,2021-2031($MILLION)
  • FIGURE 40.BRAZIL STERILITY INDICATORS MARKET,2021-2031($MILLION)
  • FIGURE 41.SAUDI ARABIA STERILITY INDICATORS MARKET,2021-2031($MILLION)
  • FIGURE 42.SOUTH AFRICA STERILITY INDICATORS MARKET,2021-2031($MILLION)
  • FIGURE 43.REST OF LAMEA STERILITY INDICATORS MARKET,2021-2031($MILLION)
  • FIGURE 44. TOP WINNING STRATEGIES, BY YEAR
  • FIGURE 45. TOP WINNING STRATEGIES, BY DEVELOPMENT
  • FIGURE 46. TOP WINNING STRATEGIES, BY COMPANY
  • FIGURE 47.PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 48.COMPETITIVE DASHBOARD
  • FIGURE 49.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
  • FIGURE 50.3M.: NET SALES ,($MILLION)
  • FIGURE 51.ANDERSON PRODUCTS, INC..: NET SALES ,($MILLION)
  • FIGURE 52.FORTIVE CORPORATION.: NET SALES ,($MILLION)
  • FIGURE 53.CARDINAL HEALTH INC..: NET SALES ,($MILLION)
  • FIGURE 54.CROSSTEX INTERNATIONAL, INC.: NET SALES ,($MILLION)
  • FIGURE 55.GETINGE AB.: NET SALES ,($MILLION)
  • FIGURE 56.GKE GMBH.: NET SALES ,($MILLION)
  • FIGURE 57.HU FRIEDY MFG. CO., LLC.: NET SALES ,($MILLION)
  • FIGURE 58.MATACHANA GROUP.: NET SALES ,($MILLION)
  • FIGURE 59.MESA LABS, INC..: NET SALES ,($MILLION)
  • FIGURE 60.MMM GROUP.: NET SALES ,($MILLION)
  • FIGURE 61.NELSON LABORATORIES, LLC.: NET SALES ,($MILLION)
  • FIGURE 62.NOXILIZER INC.: NET SALES ,($MILLION)
  • FIGURE 63.PROPPER MANUFACTURING CO., INC..: NET SALES ,($MILLION)
  • FIGURE 64.SIGMA ALDRICH.: NET SALES ,($MILLION)
  • FIGURE 65.STERIS PLC.: NET SALES ,($MILLION)
  • FIGURE 66.STRYKER CORPORATION.: NET SALES ,($MILLION)